Genetic Determinants of Neurological and Developmental Disorders
GDNDD
Genetic Determinants of Neurological and Developmental Disorders (GDNDD) is an IRB-approved research study that uses cutting-edge genome sequencing to identify disease-causing genetic variants. Since starting in 2021, the Genetic Determinants of Neurological and Developmental Disorders (GDNDD) research study team has enrolled over 300 participants.
Purpose of GDNDD
The purpose of the GDNDD study is to better understand how genetic changes affect people with neurological and developmental disorders, such as epilepsy (a seizure disorder).
Anyone with a history of seizures without a known genetic cause can participate.
For those who choose to participate, we will request a blood sample from the patient and, if possible, from two biological relatives. Additionally, the study team will collect medical history to better understand the significance of any genetic findings.
No, there is no cost to participate, and we do not provide financial compensation. However, by participating, you will receive genetic testing and potential access to genetic counseling.
- Groups who are medically underserved are often underrepresented in research.
- Rare genetic changes can have unclear relevance, especially for individuals from different backgrounds.
- GDNDD prioritizes inclusion, following the NINDS Strategic Plan and the NHGRI Strategic Vision, both of which emphasize the importance of inclusion.
Interested in participating?
Contact the study team by email at GDNDD@neurology.unc.edu or by calling (919) 445-6978.
Team
Core Study Team
Senyene Hunter, MD, PhD
Principle Investigator
Assistant Professor of Neurology
Co-founder and Research Core Leader of the 黑料网 Epilepsy Neurogenetics Initiative
Experts